Search
Monte Rosa Therapeutics Inc
GLUEAdd to Watchlist
12.130USD
-0.470-3.73%
Close 09-18 16:00（ET）
1.03BMarket Cap
LossP/E TTM
After-hours 16:04 (ET)12.250USD+0.125+1.03%
After-hours 16:04 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-3.73%
5 Days
-13.79%
1 Month
-19.29%
6 Months
-23.03%
Year to Date
-22.64%
1 Year
+75.04%
Key Figures
12.570Open
12.641High
60.24KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.07%Turnover Ratio
12.600Prev. Close
12.020Low
735.16KTurnover
LossP/E Static
2.12P/B
0.00%Div Yield TTM
-23.02%ROA
25.77052wk High
16.52Volume Ratio
-72.70MNet Profit
85.23MShares
-1.4812EPS TTM
1.61Beta
-32.62%ROE
6.23052wk Low
4.37%Amplitude
100.00%Gross Margin
1.03BMarket Cap
-8.09Reward/Risk
5.41%Risk Rate
Monte Rosa Therapeutics Inc's Score
-0.24vs previous score
Forecast8.67
Financial Health5.77
Technical4.71
Valuation Dimensions8.55
Institutional Confidence7.00
Risk Assessment4.71
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Monte Rosa Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.43/-0.38
Revenue / Forecast
8.97M/5.52M
Monte Rosa Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolGLUE
Number of employees134
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| New Enterprise Associates (NEA) | 9.11% |
| Dimension Management, L.P. | 7.71% |
| T. Rowe Price Associates, Inc. | 5.94% |
| TCG Crossover Management, LLC | 5.47% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 29.94% |
| Venture Capital | 21.43% |
| Hedge Fund | 17.28% |
| Investment Advisor/Hedge Fund | 15.68% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Monte Rosa Therapeutics Inc (GLUE)?
The current price of Monte Rosa Therapeutics Inc (GLUE) is 12.13.
What is the symbol of Monte Rosa Therapeutics Inc?
The ticker symbol of Monte Rosa Therapeutics Inc is GLUE.
What is the 52-week high of Monte Rosa Therapeutics Inc?
The 52-week high of Monte Rosa Therapeutics Inc is 25.77.
What is the 52-week low of Monte Rosa Therapeutics Inc?
The 52-week low of Monte Rosa Therapeutics Inc is 6.23.
What is the market capitalization of Monte Rosa Therapeutics Inc?
The market capitalization of Monte Rosa Therapeutics Inc is 1.03B.
Is Monte Rosa Therapeutics Inc (GLUE) currently rated as Buy, Hold, or Sell?
According to analysts, Monte Rosa Therapeutics Inc (GLUE) has an overall rating of Buy, with a price target of 28.80.
What is the Earnings Per Share (EPS TTM) of Monte Rosa Therapeutics Inc (GLUE)?
The Earnings Per Share (EPS TTM) of Monte Rosa Therapeutics Inc (GLUE) is -1.48.